RSS-Feed abonnieren
DOI: 10.1055/s-0029-1217178
An Expedient Entry to Fused [1,2,5]-Triazepine Derivatives: Extension to Fused [1,2,5]-Oxadiazine Derivatives, a New Class of Seven-Membered Heterocycles [¹]
Publikationsverlauf
Publikationsdatum:
13. Mai 2009 (online)
![](https://www.thieme-connect.de/media/synlett/200909/lookinside/thumbnails/10.1055-s-0029-1217178-1.jpg)
Abstract
This document describes an efficient synthesis of fused indole containing tricyclic [1,2,5]-triazepine derivatives from 2-cyanomethyl indole in two simple and convenient steps. This new methodology allows us to synthesize a variety of substituted [1,2,5]-triazepine derivatives in excellent yields. Further exploration of this methodology using 2-cyanomethyl indole and hydroxylamine directed us to access a new class of seven-membered fused [1,2,5]-oxadiazine derivatives in good to excellent yields.
Key words
heterocycles - indoles - fused-ring systems - [1,2,5]-triazepines - [1,2,5]-oxadiazines
IPD communication number: DRL-IPDO-IPM-00176.
-
2a
Eicher T.Hauptmann S. The Chemistry of Heterocycles 2nd ed.: Wiley-VCH; Weinheim: 2003. p.461-479 -
2b
Bellantuono C.Reggi G.Tognoni G.Garattini S. Drugs 1980, 19: 195 -
3a
Sternbach LH. J. Med. Chem. 1979, 22: 1 -
3b
Williams M. J. Med. Chem. 1983, 26: 619 -
3c
Snieckus V.Streith J. Acc. Chem. Res. 1981, 14: 348 -
3d
Itto MYA.Hasnaoui A.Riahi A.Lavergne J.-P. Tetrahedron Lett. 1997, 38: 2087 -
3e
Quan H.-J.Koyanagi J.Hagiwara K.Cui X.-R.Isshiki Y.Kondo S.Komada F.Saito S. Chem. Pharm. Bull. 2006, 54: 73 - 4
Sui Z, andWalsh SP. inventors; US Patent, 6821993B1. - 5
Lenman MM.Lewis A.Gani D. J. Chem. Soc., Perkin Trans. 1 1997, 2297 -
6a
Seebacher W.Michl G.Weis A. Tetrahedron Lett. 2002, 43: 7481 -
6b
Rezessy B.Zubocics Z.Kovacs J.Toth G. Tetrahedron 1999, 55: 5909 -
6c
Adamo MFA.Baldwin JE.Adlington RM. J. Org. Chem. 2005, 70: 3307 ; and references cited therein -
7a
Saveleva EA.Rozin YA.Kodess MI.Meervelt LV.Dehaen W.Morzherin YY.Bakulev VA. Tetrahedron 2004, 60: 5367 -
7b
Zaleska B.Trzewik B.Grochowski J.Serda P. Synthesis 2003, 2559 -
7c
Katritzky AR.Fan W.-Q.Greenhill JV. J. Org. Chem. 1991, 56: 1299 -
7d
Lenman MM.Lewis A.Gani D. J. Chem. Soc., Perkin Trans. 1 1997, 2297 -
7e
Bouteau B.Imbs J.-L.Lancelot J.-C.Barthelmebs M.Robba M. Chem. Pharm. Bull. 1991, 39: 81 -
7f
Kirchner E.Bretschneider H. Monatsh. Chem. 1971, 102: 162 - 8
Scott AI. Acc. Chem. Rev. 1970, 3: 151 -
9a
Flynn BL.Hamel E.Junk MK. J. Med. Chem. 2002, 45: 2670 -
9b
Chao W.-R.Yean D.Amin K.Green C.Jong L. J. Med. Chem. 2007, 50: 3412 -
9c
Breslin HJ.Miskowski TA.Kukla MJ.Leister WH.Winter HLD.Gauthier DA.Somers MVF.Peeters DCG.Roevens PWM. J. Med. Chem. 2002, 45: 5303 - 10
Pletnev AA.Tian Q.Larock RC. J. Org. Chem. 2002, 67: 9276 -
13a
Cho SY.Kang SK.Ahn JH.Ha JD.Choi J.-K. Tetrahedron Lett. 2006, 47: 9029 -
13b
Srivastava RM.de Morais LPF.de Melo Souto SC.Carpenter GB.de Carvalho LT. Tetrahedron Lett. 2006, 47: 3173 -
13c
Tabei K.Kawashima E.Takada T.Kato T. Chem. Pharm. Bull. 1982, 30: 3987 - 14
Butler RN.McMahon JM.McDonald PD.Pyne CS.Schambony S.McArdle P.Cunningham D. J. Chem. Soc., Perkin Trans. 1 1997, 1047 - 15
Makula D,Druet M, andGonthier B. inventors; US Patent, 3696099. - 16
Hansen DW,Hallinan EA,Awasthi AK,Metz S,Scholten JA,Snyder JS,Toth MV, andWebber RK. inventors; US Patent, 6774126B2. - 17
Takacs K,Simay A,Kiss I,Nagy PL,Hetvey M,Escery M,Szegy J,Viragh S, andNagy SJ. inventors; US Patent, 4308270.
References and notes
IPD communication number: DRL-IPDO-IPM-00176.
11
1-[2-(4-Methoxyphenyl)-2-oxoethyl]-1
H
-indole-2-carbonitrile (7a); Typical Procedure
To a
solution of 1H-indole-2-carbonitrile
(5; 10.0 g, 0.07 mol) in acetone (100 mL)
were added p-methoxyphenacyl bromide
(6; 17.6 g, 0.077 mol) and anhyd K2CO3 (38.6
g, 0.28 mol) followed by TBAI (0.37 g, 0.001 mol) and the resulting
mixture was stirred at reflux temperature for 2 h. Acetone was removed
under vacuum and the residue was quenched with H2O and
filtered. The crude product 7a was then
recrystallized from MeOH to give the pure product as a solid. Yield:
16.0 g (78%); mp 126 ˚C. FT IR (KBr): 2223, 1682,
1602 cm-¹. ¹H NMR
(400 MHz, DMSO-d
6): δ = 3.89 (s,
3 H, OMe), 6.05 (s, 2 H, NCH2), 7.15 (d, J = 8.4 Hz, 2 H, Ar), 7.21 (t, J = 7.6 Hz, 1 H, Ar), 7.37 (t, J = 8.4 Hz, 1 H, Ar), 7.52 (s,
1 H, indole CH), 7.62 (d, J = 8.8
Hz, 1 H, Ar), 7.73 (d, J = 8.4
Hz, 1 H, Ar), 8.13 (d, J = 8.4
Hz, 2 H, Ar). ¹³C NMR (50 MHz, DMSO-d
6): δ = 50.5,
55.6, 109.9, 110.5, 113.4, 113.7, 114.2, 121.6, 122.5, 126.1, 126.2,
127.1, 130.4, 138.1, 164.4, 189.6. HRMS (ES): m/z calcd for C18H15N2O2 [M + 1]:
291.1134; found: 291.1121.
[1,2,5]-Triazepine Derivative 8a; Typical Procedure A solution of 7a (10.2 g, 0.035 mol) in hydrazine hydrate (50 mL) was refluxed for 2 h. It was cooled to r.t. and filtered to give compound 8a as a solid. Yield: 9.2 g (86%); mp 258-260 ˚C. FT IR (KBr): 3164, 3293, 3053, 1638 cm-¹. ¹H NMR (400 MHz, DMSO-d 6): δ = 3.81 (s, 3 H, OMe), 7.04 (d, J = 8.8 Hz, 2 H, Ar), 7.27 (s, 1 H, indole CH), 7.30 (t, J = 8.0 Hz, 1 H, Ar), 7.40 (t, J = 8.0 Hz, 1 H, Ar), 7.73 (d, J = 8.8 Hz, 2 H, Ar), 7.82 (d, J = 8.0 Hz, 1 H, Ar), 8.14 (s, 1 H, NCH=C), 8.20 (d, J = 8.8 Hz, 1 H, Ar), 10.99 (br s, 1 H, NH). ¹³C NMR (50 MHz): δ = 55.3, 101.1, 102.7, 112.1, 114.0, 122.0, 122.3, 123.5, 124.4, 124.5, 126.8, 126.9, 127.3, 132.2, 157.3, 159.4. HRMS (ES): m/z calcd for C18H17N4O [M + 1]: 305.1402; found: 305.1403.
18
[1,2,5]-Oxadiazine
Derivative 9a; Typical Procedure
A mixture of 7a (18.0 g, 0.062 mol), HONH2˙HCl
(13.0 g, 0.187 mol) and Na2CO3 (19.8 g, 0.187
mol) in MeOH (100 mL) was refluxed for 30 min. The reaction mixture
was quenched with ice-water and filtered. The crude product thus obtained
was recrystallized from MeOH-acetone mixture to provide
pure 9a. Yield: 16.6 g (88%);
mp 220-222 ˚C. FT IR: 3403, 1629 cm-¹. ¹H
NMR (400 MHz, DMSO-d
6): δ = 3.81
(s, 3 H, OMe), 6.87 (s, 1 H, indole CH), 7.05 (d, J = 8.8 Hz,
2 H, Ar), 7.18 (t, J = 7.2 Hz,
1 H, Ar), 7.27 (t, J = 7.2 Hz, 1
H, Ar), 7.63 (s, 1 H, NCH=C), 7.63-7,68 (m, 1
H, Ar), 7.67 (d, J = 8.4 Hz,
2 H, Ar), 7.99 (d, J = 8.4 Hz,
1 H, Ar), 8.29 (s, 1 H, NH), 10.37 (s, 1 H, =NH). ¹³C
NMR (50 MHz, DMSO-d
6): δ = 55.3,
96.0, 99.3, 110.7, 114.2, 120.8, 121.5, 122.1, 123.6, 124.4, 125.3,
126.4, 127.7, 132.4, 140.4, 159.4. HRMS (ES): m/z calcd for C18H16N3O2 [M + 1]: 306.1243;
found: 305.1234.